Literature DB >> 23627490

Sympathetic nervous system function and dysfunction in chronic hemodialysis patients.

Dvora Rubinger1, Rebecca Backenroth, Dan Sapoznikov.   

Abstract

Adequate sympathetic nervous system activation is essential for the compensatory mechanisms of blood pressure maintenance during the hemodialysis (HD) procedure. Chronic sympathetic nervous system overactivity, however, may lead to the development of hypertension and cardiovascular disease in HD patients. The present review focuses on recent findings on the sympathetic nervous system activity in these patients. Sympathetic overactivity has been demonstrated directly by muscle sympathetic nerve activity recordings (MSNA) in chronic renal disease, but only rarely in HD patients. In the latter, sympathetic activity has mostly been assessed using indirect methodology. Decreased heart rate variability, increased blood pressure variability (BPV), and suppressed baroreflex function are believed to represent chronic sympathetic overactivity in HD patients. The HD procedure and ultrafiltration are associated with enhanced sympathetic activity and baroreflex activation. During most episodes of intradialytic hypotension, the baroreflex is adequately activated; sympathetic withdrawal with bradycardia, however, has been reported during excessive hypovolemia. Sympathetic overactivity is also believed to be a mechanism associated with intradialytic hypertensive episodes and refractory hypertension. While successful renal transplantation is associated with improvement of heart rate variability (HRV), improvement and restoration of baroreflex function, persistent sympathetic overactivity has been documented in transplanted patients using MSNA recordings. Decreased HRV and baroreflex function have been reported to be associated with increased mortality and morbidity in HD patients. The predictive value of sympathetic outflow assessed by MSNA has yet to be determined. Optimization of HD treatment, pharmacological interventions, and renal sympathetic denervation are several approaches targeting sympathetic overactivity to improve cardiovascular morbidity and mortality.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23627490     DOI: 10.1111/sdi.12093

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  27 in total

1.  Heart rate variability is an indicator for intradialytic hypotension among chronic hemodialysis patients.

Authors:  Yu-Ming Chang; Chih-Chung Shiao; Kuo-Chi Chang; I-Ling Chen; Chuan-Lan Yang; Show-Chin Leu; Hung-Li Su; Jsun-Liang Kao; Shih-Ching Tsai; Rong-Na Jhen
Journal:  Clin Exp Nephrol       Date:  2015-10-28       Impact factor: 2.801

2.  Morphological evaluation of sympathetic renal innervation in patients with autosomal dominant polycystic kidney disease.

Authors:  Valentina Rovella; Manuel Scimeca; Elena Giannini; Adriana D'Ercole; Erica Giacobbi; Annalisa Noce; Gabriele D'Urso; Alessandro Anselmo; Pierluigi Bove; Giuseppe Santeusanio; Elena Bonanno; Maurizio Casasco; Silvestro Mauriello; Nicola Di Daniele; Alessandro Mauriello; Lucia Anemona
Journal:  J Nephrol       Date:  2019-04-25       Impact factor: 3.902

3.  Intradialytic acid-base changes and organic anion production during high versus low bicarbonate hemodialysis.

Authors:  Sarah Park; William Paredes; Matthew Custodio; Narender Goel; Deepak Sapkota; Anusha Bandla; Robert I Lynn; Suman M Reddy; Thomas H Hostetter; Matthew K Abramowitz
Journal:  Am J Physiol Renal Physiol       Date:  2020-04-20

4.  Dynamics of Cardiac Autonomic Responses During Hemodialysis Measured by Heart Rate Variability and Skin Sympathetic Nerve Activity: The Impact of Interdialytic Weight Gain.

Authors:  Yike Zhang; Jing Wang; Yantao Xing; Chang Cui; Hongyi Cheng; Zhenye Chen; Hongwu Chen; Chengyu Liu; Ningning Wang; Minglong Chen
Journal:  Front Physiol       Date:  2022-05-16       Impact factor: 4.755

5.  Correlation between indexes of autonomic maneuvers and heart rate variability in hemodialysis patients.

Authors:  Carlos Felipe Delmondes Vieira; Márcia Maria Oliveira Lima; Henrique Silveira Costa; Karen Marina Alves Diniz; João Paulo Lemos Guião; Frederico Lopes Alves; Emílio Henrique Maciel; Vanessa Gomes Brandao; Pedro Henrique Scheidt Figueiredo
Journal:  Clin Auton Res       Date:  2016-03-15       Impact factor: 4.435

6.  Preserved autonomic heart rate modulation in chronic renal failure patients in response to hemodialysis and orthostatism.

Authors:  Claudia Lerma; Hortensia González; Hector Pérez-Grovas; Marco V José; Oscar Infante
Journal:  Clin Exp Nephrol       Date:  2014-05-30       Impact factor: 2.801

7.  Study protocol for a single-blind, placebo-controlled randomised trial of Tianjiu effects in patients with intradialytic hypotension.

Authors:  Ming-Yen Tsai; Yu-Jen Su; Hwee-Yeong Ng; Shih-Yu Chen; Yu-Chuen Huang; Chien-Hsing Wu; Yung-Hsiang Chen
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

Review 8.  Obesity-related metabolic syndrome: mechanisms of sympathetic overactivity.

Authors:  Maria Paola Canale; Simone Manca di Villahermosa; Giuliana Martino; Valentina Rovella; Annalisa Noce; Antonino De Lorenzo; Nicola Di Daniele
Journal:  Int J Endocrinol       Date:  2013-10-31       Impact factor: 3.257

9.  The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease.

Authors:  Caroline C Pelletier; Laetitia Koppe; Pascaline M Alix; Emilie Kalbacher; Marine L Croze; Aoumeur Hadj-Aissa; Denis Fouque; Fitsum Guebre-Egziabher; Christophe O Soulage
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

10.  Increased Sympathetic Renal Innervation in Hemodialysis Patients Is the Anatomical Substrate of Sympathetic Hyperactivity in End-Stage Renal Disease.

Authors:  Alessandro Mauriello; Valentina Rovella; Lucia Anemona; Francesca Servadei; Elena Giannini; Pierluigi Bove; Alessandro Anselmo; Gerry Melino; Nicola Di Daniele
Journal:  J Am Heart Assoc       Date:  2015-11-26       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.